EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer

NCT00896961 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

120

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Stage I Adult Soft Tissue Sarcoma
Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage II Adult Soft Tissue Sarcoma
Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage III Adult Soft Tissue Sarcoma
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity

Interventions

DRUG: EF5
OTHER: diagnostic laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)